Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Non-malignant skin disease‏‎ (478 revisions)
  2. Main Page‏‎ (406 revisions)
  3. Kidney tumours‏‎ (402 revisions)
  4. Neuropathology tumours‏‎ (398 revisions)
  5. Stomach‏‎ (381 revisions)
  6. Placenta‏‎ (355 revisions)
  7. Neuropathology‏‎ (343 revisions)
  8. Breast pathology‏‎ (332 revisions)
  9. Medical kidney diseases‏‎ (329 revisions)
  10. Gastrointestinal tract polyps‏‎ (322 revisions)
  11. Uterine cervix‏‎ (315 revisions)
  12. Prostate gland‏‎ (309 revisions)
  13. Dermatologic neoplasms‏‎ (301 revisions)
  14. Ditzels‏‎ (297 revisions)
  15. Invasive breast cancer‏‎ (291 revisions)
  16. Medical liver disease‏‎ (289 revisions)
  17. Colon‏‎ (287 revisions)
  18. Forensic pathology‏‎ (279 revisions)
  19. Endometrium‏‎ (270 revisions)
  20. Chondro-osseous tumours‏‎ (268 revisions)
  21. Esophagus‏‎ (265 revisions)
  22. Prostate cancer‏‎ (263 revisions)
  23. Ovarian tumours‏‎ (256 revisions)
  24. Melanocytic lesions‏‎ (246 revisions)
  25. Soft tissue lesions‏‎ (245 revisions)
  26. Pancreas‏‎ (244 revisions)
  27. Testis‏‎ (232 revisions)
  28. An introduction to head and neck pathology‏‎ (232 revisions)
  29. Salivary glands‏‎ (231 revisions)
  30. Medical lung diseases‏‎ (225 revisions)
  31. Urothelium‏‎ (213 revisions)
  32. Lymph node pathology‏‎ (212 revisions)
  33. Thyroid gland‏‎ (211 revisions)
  34. Duodenum‏‎ (198 revisions)
  35. Gynecologic cytopathology‏‎ (192 revisions)
  36. Dermatopathology‏‎ (190 revisions)
  37. Stains‏‎ (189 revisions)
  38. Basics‏‎ (186 revisions)
  39. Long power list‏‎ (181 revisions)
  40. Inflammatory bowel disease‏‎ (175 revisions)
  41. Liver neoplasms‏‎ (173 revisions)
  42. Lung tumours‏‎ (169 revisions)
  43. Inflammatory skin disorders‏‎ (167 revisions)
  44. Autopsy‏‎ (154 revisions)
  45. Neuromuscular pathology‏‎ (153 revisions)
  46. Immunohistochemical staining‏‎ (153 revisions)
  47. Uterine tumours‏‎ (153 revisions)
  48. Adrenal gland‏‎ (152 revisions)
  49. Neurodegenerative diseases‏‎ (151 revisions)
  50. Eye‏‎ (144 revisions)
  51. Fibroblastic/myofibroblastic tumours‏‎ (143 revisions)
  52. Lymphoma‏‎ (140 revisions)
  53. Liver pathology‏‎ (138 revisions)
  54. Colorectal tumours‏‎ (135 revisions)
  55. Malignant melanoma‏‎ (135 revisions)
  56. Peripheral nerve sheath tumours‏‎ (133 revisions)
  57. Vulva‏‎ (132 revisions)
  58. Gallbladder‏‎ (130 revisions)
  59. Heart valves‏‎ (127 revisions)
  60. Gestational trophoblastic disease‏‎ (125 revisions)
  61. Germ cell tumours‏‎ (119 revisions)
  62. Heart‏‎ (116 revisions)
  63. Vermiform appendix‏‎ (113 revisions)
  64. Bone‏‎ (112 revisions)
  65. Dermal cysts‏‎ (112 revisions)
  66. Microorganisms‏‎ (108 revisions)
  67. Vasculitides‏‎ (108 revisions)
  68. Endometrial carcinoma‏‎ (108 revisions)
  69. Small intestine‏‎ (103 revisions)
  70. Meningioma‏‎ (102 revisions)
  71. Adipocytic tumours‏‎ (102 revisions)
  72. Small cell lymphomas‏‎ (101 revisions)
  73. Pathology links‏‎ (100 revisions)
  74. Cases‏‎ (100 revisions)
  75. Vascular disease‏‎ (97 revisions)
  76. Amyloid‏‎ (95 revisions)
  77. Adenocarcinoma of the lung‏‎ (93 revisions)
  78. Diffuse lung diseases‏‎ (91 revisions)
  79. Pituitary gland‏‎ (91 revisions)
  80. Vascular tumours‏‎ (90 revisions)
  81. An introduction to gynecologic pathology‏‎ (89 revisions)
  82. Pulmonary cytopathology‏‎ (89 revisions)
  83. Short power list‏‎ (88 revisions)
  84. Non-invasive breast carcinoma‏‎ (87 revisions)
  85. Fungi‏‎ (86 revisions)
  86. Urothelial carcinoma‏‎ (85 revisions)
  87. Celiac sprue‏‎ (83 revisions)
  88. Neurohistology‏‎ (82 revisions)
  89. Parathyroid glands‏‎ (82 revisions)
  90. Cytopathology‏‎ (79 revisions)
  91. Spleen‏‎ (79 revisions)
  92. Pulmonary pathology‏‎ (78 revisions)
  93. Surgical margins‏‎ (75 revisions)
  94. Thyroid cytopathology‏‎ (74 revisions)
  95. Quality‏‎ (71 revisions)
  96. Mesothelial cytopathology‏‎ (70 revisions)
  97. Pediatric gastrointestinal pathology‏‎ (70 revisions)
  98. Colorectal adenocarcinoma‏‎ (70 revisions)
  99. MEDITECH‏‎ (70 revisions)
  100. Viruses‏‎ (70 revisions)
  101. Libre Pathology‏‎ (69 revisions)
  102. Products of conception‏‎ (68 revisions)
  103. Papillary renal cell carcinoma‏‎ (67 revisions)
  104. Bacteria‏‎ (67 revisions)
  105. Haematopathology‏‎ (67 revisions)
  106. Uterine tubes‏‎ (66 revisions)
  107. Endometrial hyperplasia‏‎ (66 revisions)
  108. Asphyxial deaths‏‎ (66 revisions)
  109. Traditional adenoma‏‎ (65 revisions)
  110. Spot diagnoses‏‎ (65 revisions)
  111. Gross pathology‏‎ (65 revisions)
  112. Penis‏‎ (65 revisions)
  113. Molecular pathology‏‎ (62 revisions)
  114. Thymus‏‎ (62 revisions)
  115. Gastrointestinal stromal tumour‏‎ (62 revisions)
  116. Anus‏‎ (62 revisions)
  117. Oral pathology‏‎ (62 revisions)
  118. Uterus‏‎ (62 revisions)
  119. Squamous cell carcinoma‏‎ (61 revisions)
  120. Clear cell renal cell carcinoma‏‎ (61 revisions)
  121. Bullous diseases‏‎ (61 revisions)
  122. Femoral head‏‎ (60 revisions)
  123. Extramammary Paget disease‏‎ (60 revisions)
  124. Hodgkin lymphoma‏‎ (60 revisions)
  125. Chondrosarcoma‏‎ (59 revisions)
  126. Small round cell tumours‏‎ (59 revisions)
  127. Rheumatoid arthritis‏‎ (59 revisions)
  128. Odontogenic tumours and cysts‏‎ (58 revisions)
  129. Pediatric pathology‏‎ (58 revisions)
  130. Vas deferens‏‎ (58 revisions)
  131. Hereditary leiomyomatosis and renal cell carcinoma syndrome‏‎ (57 revisions)
  132. LP:Sandbox‏‎ (57 revisions)
  133. Head and neck cytopathology‏‎ (57 revisions)
  134. Succinate dehydrogenase-deficient renal cell carcinoma‏‎ (56 revisions)
  135. Angiomyolipoma‏‎ (55 revisions)
  136. Cardiac tumours‏‎ (55 revisions)
  137. Endometriosis‏‎ (54 revisions)
  138. Spindle cell lesions‏‎ (54 revisions)
  139. Diffuse large B-cell lymphoma‏‎ (54 revisions)
  140. Metastases‏‎ (54 revisions)
  141. Sertoli-Leydig cell tumour‏‎ (54 revisions)
  142. An introduction to gastrointestinal pathology‏‎ (54 revisions)
  143. Non-small cell lung carcinoma‏‎ (53 revisions)
  144. Clinical history‏‎ (53 revisions)
  145. Trophoblast‏‎ (53 revisions)
  146. Intracranial hematomas‏‎ (52 revisions)
  147. Prostate cancer grading‏‎ (52 revisions)
  148. Urinary bladder‏‎ (52 revisions)
  149. Crystals in body fluids‏‎ (51 revisions)
  150. Clear cell papillary renal cell tumour‏‎ (51 revisions)
  151. Osteoarthritis‏‎ (50 revisions)
  152. Renal oncocytoma‏‎ (50 revisions)
  153. Gastrointestinal cytopathology‏‎ (50 revisions)
  154. Intraoperative consultation‏‎ (50 revisions)
  155. Ampulla of Vater‏‎ (49 revisions)
  156. Tuberous sclerosis‏‎ (49 revisions)
  157. Malignant mesothelioma‏‎ (49 revisions)
  158. Pheochromocytoma‏‎ (48 revisions)
  159. Neuroendocrine neoplasms‏‎ (48 revisions)
  160. TFE3-rearranged renal cell carcinoma‏‎ (47 revisions)
  161. Congenital heart disease‏‎ (47 revisions)
  162. L4E rule 1-3 (2014)‏‎ (47 revisions)
  163. Chromophobe renal cell carcinoma‏‎ (47 revisions)
  164. Granular cell tumour‏‎ (46 revisions)
  165. Rhabdomyosarcoma‏‎ (45 revisions)
  166. Hypertension‏‎ (45 revisions)
  167. Astrocytoma‏‎ (45 revisions)
  168. Pulmonary embolism‏‎ (45 revisions)
  169. Urine cytopathology‏‎ (45 revisions)
  170. Gunshot wounds‏‎ (45 revisions)
  171. Desmoid-type fibromatosis‏‎ (44 revisions)
  172. Chromosomal translocations‏‎ (44 revisions)
  173. TFEB-rearranged renal cell carcinoma‏‎ (44 revisions)
  174. Breast cytopathology‏‎ (44 revisions)
  175. Craniopharyngioma‏‎ (43 revisions)
  176. Diverticular disease‏‎ (43 revisions)
  177. Joints‏‎ (43 revisions)
  178. Familial adenomatous polyposis‏‎ (43 revisions)
  179. Level 4 equivalent of 2014‏‎ (42 revisions)
  180. Renal mucinous tubular and spindle cell carcinoma‏‎ (42 revisions)
  181. Seminoma‏‎ (42 revisions)
  182. Mucinous carcinoma‏‎ (42 revisions)
  183. ELOC-mutated renal cell carcinoma‏‎ (42 revisions)
  184. Sarcoidosis‏‎ (42 revisions)
  185. Basal cell carcinoma‏‎ (42 revisions)
  186. OP:Sandbox3‏‎ (42 revisions)
  187. SMARCB1-deficient renal medullary carcinoma‏‎ (42 revisions)
  188. Secretory carcinoma of the salivary gland‏‎ (42 revisions)
  189. Small cell carcinoma‏‎ (41 revisions)
  190. Renal tumours with eosinophilic cytoplasm‏‎ (41 revisions)
  191. Leiomyoma‏‎ (41 revisions)
  192. Ependymoma‏‎ (41 revisions)
  193. Lymph node metastasis‏‎ (41 revisions)
  194. Sjögren syndrome‏‎ (40 revisions)
  195. Signet ring cell carcinoma‏‎ (40 revisions)
  196. Nephrogenic adenoma‏‎ (40 revisions)
  197. Informatics‏‎ (40 revisions)
  198. Programmed death-ligand 1‏‎ (39 revisions)
  199. Hyperplastic polyp‏‎ (39 revisions)
  200. P16‏‎ (39 revisions)
  201. Cystic kidney diseases‏‎ (39 revisions)
  202. Giant cell arteritis‏‎ (39 revisions)
  203. Leukemia‏‎ (38 revisions)
  204. Robbins and Cotran 9th Edition Questions‏‎ (38 revisions)
  205. Papillary thyroid carcinoma‏‎ (38 revisions)
  206. Nephrotic syndrome‏‎ (38 revisions)
  207. Lymphovascular invasion‏‎ (38 revisions)
  208. Seborrheic keratosis‏‎ (38 revisions)
  209. Acquired cystic disease-associated renal cell carcinoma‏‎ (38 revisions)
  210. Schwannoma‏‎ (37 revisions)
  211. Glomus tumour‏‎ (37 revisions)
  212. Cardiomyopathy‏‎ (37 revisions)
  213. Metaphyseal fibrous defect‏‎ (37 revisions)
  214. Neurofibromatosis‏‎ (37 revisions)
  215. Pneumonia‏‎ (36 revisions)
  216. Total nephrectomy for tumour grossing‏‎ (36 revisions)
  217. Serous carcinoma of the ovary‏‎ (36 revisions)
  218. NUT carcinoma‏‎ (36 revisions)
  219. Renal angiomyoadenomatous tumour‏‎ (35 revisions)
  220. Prostate-specific antigen‏‎ (35 revisions)
  221. Lymph nodes‏‎ (35 revisions)
  222. Helicobacter gastritis‏‎ (35 revisions)
  223. Renal transplant pathology‏‎ (34 revisions)
  224. Medullary thyroid carcinoma‏‎ (34 revisions)
  225. Heart transplant pathology‏‎ (34 revisions)
  226. Cancer staging systems‏‎ (34 revisions)
  227. Thrombotic microangiopathy‏‎ (34 revisions)
  228. Low-grade oncocytic renal tumour‏‎ (34 revisions)
  229. Steatohepatitis‏‎ (34 revisions)
  230. GATA3‏‎ (34 revisions)
  231. Multiple endocrine neoplasia‏‎ (33 revisions)
  232. Pulmonary alveolar proteinosis‏‎ (33 revisions)
  233. Typical carcinoid lung tumour‏‎ (33 revisions)
  234. Sessile serrated adenoma‏‎ (33 revisions)
  235. Langerhans cell histiocytosis‏‎ (33 revisions)
  236. Squamous cell carcinoma of the lung‏‎ (33 revisions)
  237. Acinic cell carcinoma‏‎ (33 revisions)
  238. Twin placentas‏‎ (33 revisions)
  239. Cervical polyps‏‎ (33 revisions)
  240. Squamous cell carcinoma of the head and neck‏‎ (33 revisions)
  241. Intraductal carcinoma of the prostate‏‎ (33 revisions)
  242. Fibromatoses‏‎ (33 revisions)
  243. Gastritis‏‎ (33 revisions)
  244. CSF cytopathology‏‎ (32 revisions)
  245. Urothelial dysplasia‏‎ (32 revisions)
  246. Principles of gross pathology‏‎ (32 revisions)
  247. Fetal autopsy‏‎ (32 revisions)
  248. Ovary‏‎ (32 revisions)
  249. Glioblastoma‏‎ (32 revisions)
  250. Esophageal adenocarcinoma‏‎ (32 revisions)
  251. Intranodal palisaded myofibroblastoma‏‎ (32 revisions)
  252. Yolk sac tumour‏‎ (32 revisions)
  253. Oligodendroglioma‏‎ (31 revisions)
  254. Lung cancer staging‏‎ (31 revisions)
  255. Paraganglioma‏‎ (31 revisions)
  256. Nasopharyngeal carcinoma‏‎ (31 revisions)
  257. Radiation changes‏‎ (31 revisions)
  258. Plasma cell neoplasms‏‎ (31 revisions)
  259. Granuloma‏‎ (31 revisions)
  260. Microphotography‏‎ (31 revisions)
  261. Adenocarcinoma of the urinary bladder‏‎ (31 revisions)
  262. Small cell carcinoma of the lung‏‎ (31 revisions)
  263. Sarcoma with CIC-rearrangement‏‎ (31 revisions)
  264. Critical values‏‎ (31 revisions)
  265. Lynch syndrome‏‎ (31 revisions)
  266. Chordoma‏‎ (31 revisions)
  267. Pleomorphic adenoma‏‎ (30 revisions)
  268. Pineal gland‏‎ (30 revisions)
  269. Leiomyosarcoma‏‎ (30 revisions)
  270. Breast grossing‏‎ (30 revisions)
  271. Pathology reports‏‎ (30 revisions)
  272. Cartilage‏‎ (30 revisions)
  273. Micropapillary urothelial carcinoma‏‎ (30 revisions)
  274. Colorectal cancer staging‏‎ (30 revisions)
  275. Orchiectomy grossing‏‎ (30 revisions)
  276. Pediatric kidney tumours‏‎ (30 revisions)
  277. Cytogenetics Review Questions‏‎ (30 revisions)
  278. Programmed cell death 1‏‎ (30 revisions)
  279. Urachal carcinoma‏‎ (30 revisions)
  280. ALK translocation renal cell carcinoma‏‎ (29 revisions)
  281. Multilocular cystic renal neoplasm of low malignant potential‏‎ (29 revisions)
  282. Adenoid cystic carcinoma‏‎ (29 revisions)
  283. Mucoepidermoid carcinoma‏‎ (29 revisions)
  284. Cystic tumour of the atrioventricular nodal region‏‎ (29 revisions)
  285. Hemophagocytic syndrome‏‎ (29 revisions)
  286. Lung carcinoma with ALK rearrangement‏‎ (29 revisions)
  287. Teratoma‏‎ (29 revisions)
  288. Tubulocystic carcinoma of the kidney‏‎ (29 revisions)
  289. Waffle diagnosis‏‎ (28 revisions)
  290. Libre Pathology news‏‎ (28 revisions)
  291. Vagina‏‎ (28 revisions)
  292. TRK fusions‏‎ (28 revisions)
  293. Wilms tumour‏‎ (28 revisions)
  294. Peritoneum‏‎ (28 revisions)
  295. Urothelial carcinoma in situ‏‎ (28 revisions)
  296. Squamous cell carcinoma of the skin‏‎ (28 revisions)
  297. Embryonal carcinoma‏‎ (28 revisions)
  298. Quiz:L4E uropathology (2014)‏‎ (28 revisions)
  299. Warthin tumour‏‎ (28 revisions)
  300. Acute appendicitis‏‎ (28 revisions)
  301. Polymorphous adenocarcinoma‏‎ (27 revisions)
  302. Pathology requisitions‏‎ (27 revisions)
  303. Cystoprostatectomy grossing‏‎ (27 revisions)
  304. Molecular pathology tests‏‎ (27 revisions)
  305. Pneumocytoma‏‎ (27 revisions)
  306. Anastomosing hemangioma of the kidney‏‎ (27 revisions)
  307. Burkitt lymphoma‏‎ (27 revisions)
  308. Zoon vulvitis‏‎ (27 revisions)
  309. Neuroanatomy‏‎ (27 revisions)
  310. End-stage kidney‏‎ (27 revisions)
  311. Angiosarcoma‏‎ (26 revisions)
  312. Sudden natural death‏‎ (26 revisions)
  313. Mucinous cystadenoma of the ovary‏‎ (26 revisions)
  314. Ileocecal valve‏‎ (26 revisions)
  315. Cytogenetics‏‎ (26 revisions)
  316. Pseudomembranous colitis‏‎ (26 revisions)
  317. Starvation‏‎ (26 revisions)
  318. Adrenocortical carcinoma‏‎ (26 revisions)
  319. Granulomatous prostatitis‏‎ (26 revisions)
  320. Squamous cell carcinoma of the penis‏‎ (26 revisions)
  321. KRAS mutation‏‎ (26 revisions)
  322. Leydig cell tumour‏‎ (26 revisions)
  323. Neuroendocrine tumour of the pancreas‏‎ (26 revisions)
  324. Pleural invasion‏‎ (25 revisions)
  325. Tuberous sclerosis-associated renal cell carcinoma‏‎ (25 revisions)
  326. Fecal material‏‎ (25 revisions)
  327. Goblet cell adenocarcinoma‏‎ (25 revisions)
  328. Brenner tumour‏‎ (25 revisions)
  329. Classification of urothelial carcinoma by immunohistochemistry‏‎ (25 revisions)
  330. Cancer‏‎ (25 revisions)
  331. Complex endometrial hyperplasia‏‎ (25 revisions)
  332. Case:Blank‏‎ (25 revisions)
  333. Serous cystadenoma of the ovary‏‎ (25 revisions)
  334. Mixed germ cell tumour‏‎ (25 revisions)
  335. Foreign material‏‎ (25 revisions)
  336. Atypical teratoid/rhabdoid tumour‏‎ (25 revisions)
  337. Prostate cancer staging‏‎ (25 revisions)
  338. Parathyroid hyperplasia‏‎ (25 revisions)
  339. Autosomal dominant polycystic kidney disease‏‎ (25 revisions)
  340. Medulloblastoma‏‎ (25 revisions)
  341. Carcinoma ex pleomorphic adenoma‏‎ (25 revisions)
  342. Clear cell carcinoma‏‎ (24 revisions)
  343. Eccrine spiradenoma‏‎ (24 revisions)
  344. Necrosis‏‎ (24 revisions)
  345. Prostatic stromal tumour of uncertain malignant potential‏‎ (24 revisions)
  346. Renal hybrid oncocytic/chromophobe tumour‏‎ (24 revisions)
  347. Biphenotypic sinonasal sarcoma‏‎ (24 revisions)
  348. Hemangioma‏‎ (24 revisions)
  349. Rosai-Dorfman disease‏‎ (24 revisions)
  350. Cystic nephroma, adult type‏‎ (24 revisions)
  351. Crohn's disease‏‎ (24 revisions)
  352. Psammoma bodies‏‎ (24 revisions)
  353. L4E rule 7-8 (2014)‏‎ (24 revisions)
  354. Large epithelioid tumours‏‎ (24 revisions)
  355. Pathology for medical students‏‎ (24 revisions)
  356. Germ cell neoplasia in situ‏‎ (24 revisions)
  357. Parathyroid adenoma‏‎ (24 revisions)
  358. Von Hippel-Lindau disease‏‎ (24 revisions)
  359. Adenocarcinoma‏‎ (24 revisions)
  360. Panniculitis‏‎ (24 revisions)
  361. Anatomical pathology laboratory processes‏‎ (23 revisions)
  362. Course:Introduction to Neuropathology‏‎ (23 revisions)
  363. Syphilis‏‎ (23 revisions)
  364. Nodular hyperplasia of the prostate gland‏‎ (23 revisions)
  365. Pulmonary hypertension‏‎ (23 revisions)
  366. Squamous intraepithelial lesion of the uterine cervix‏‎ (23 revisions)
  367. Barrett's esophagus‏‎ (23 revisions)
  368. Choriocarcinoma‏‎ (23 revisions)
  369. Lymphoepithelioma-like carcinoma of the urinary bladder‏‎ (23 revisions)
  370. Chondromyxoid fibroma‏‎ (23 revisions)
  371. Desquamative interstitial pneumonia‏‎ (23 revisions)
  372. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features‏‎ (23 revisions)
  373. Stomach carcinoma‏‎ (23 revisions)
  374. Epithelioid hemangioendothelioma‏‎ (23 revisions)
  375. Endometrioid endometrial carcinoma‏‎ (23 revisions)
  376. In-transit metastasis‏‎ (23 revisions)
  377. Squamous cell carcinoma of the urinary bladder‏‎ (23 revisions)
  378. Apocrine carcinoma of the breast‏‎ (23 revisions)
  379. Sarcina‏‎ (23 revisions)
  380. Liver metastasis‏‎ (22 revisions)
  381. Plasma cell‏‎ (22 revisions)
  382. Fibroadenoma‏‎ (22 revisions)
  383. Pseudomelanosis coli‏‎ (22 revisions)
  384. Pilocytic astrocytoma‏‎ (22 revisions)
  385. Histology artifacts‏‎ (22 revisions)
  386. Electron microscopy‏‎ (22 revisions)
  387. Leydig cell hyperplasia‏‎ (22 revisions)
  388. Metanephric adenoma‏‎ (22 revisions)
  389. Brain metastasis‏‎ (22 revisions)
  390. Renal oncocytosis‏‎ (22 revisions)
  391. Vascular malformations‏‎ (22 revisions)
  392. Diagnosis‏‎ (22 revisions)
  393. Small bowel pseudomelanosis‏‎ (22 revisions)
  394. Pulmonary blastoma‏‎ (22 revisions)
  395. Hepatocellular carcinoma‏‎ (22 revisions)
  396. Smoking‏‎ (22 revisions)
  397. Follicular dendritic cell sarcoma‏‎ (22 revisions)
  398. Malakoplakia‏‎ (22 revisions)
  399. Atypical adenomatous hyperplasia of the lung‏‎ (22 revisions)
  400. Adamantinoma‏‎ (22 revisions)
  401. Cribriform adenocarcinoma of the minor salivary gland‏‎ (22 revisions)
  402. Proliferative phase endometrium‏‎ (22 revisions)
  403. Salivary duct carcinoma‏‎ (21 revisions)
  404. Case 1‏‎ (21 revisions)
  405. Parathyroid carcinoma‏‎ (21 revisions)
  406. Eosinophilic esophagitis‏‎ (21 revisions)
  407. Diagnostic size cutoffs‏‎ (21 revisions)
  408. Gout‏‎ (21 revisions)
  409. Papillary cystadenoma of the epididymis‏‎ (21 revisions)
  410. IgG4-related systemic diseases‏‎ (21 revisions)
  411. Fundic gland polyp‏‎ (21 revisions)
  412. Red blood cell‏‎ (21 revisions)
  413. Autoimmune hepatitis‏‎ (21 revisions)
  414. Pressure ulcer‏‎ (21 revisions)
  415. Lichen sclerosus‏‎ (21 revisions)
  416. Histiocytoses‏‎ (21 revisions)
  417. Light microscopy‏‎ (21 revisions)
  418. SMARCB1‏‎ (21 revisions)
  419. Thyroid imaging reporting and data system‏‎ (21 revisions)
  420. Lymphocytic colitis‏‎ (21 revisions)
  421. Systemic lupus erythematosus‏‎ (21 revisions)
  422. Human immunodeficiency virus‏‎ (21 revisions)
  423. Sinonasal undifferentiated carcinoma‏‎ (21 revisions)
  424. Loop electrosurgical excision procedure‏‎ (21 revisions)
  425. Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis‏‎ (21 revisions)
  426. Intestinal metaplasia of the stomach‏‎ (21 revisions)
  427. Immune thrombocytopenic purpura‏‎ (21 revisions)
  428. Reactive gastropathy‏‎ (21 revisions)
  429. Adenocarcinoma of the rete testis‏‎ (21 revisions)
  430. Lymphangioleiomyomatosis‏‎ (21 revisions)
  431. Abusive head trauma‏‎ (21 revisions)
  432. Prostate chips grossing‏‎ (21 revisions)
  433. Low-grade squamous intraepithelial lesion‏‎ (20 revisions)
  434. Kidney cancer staging‏‎ (20 revisions)
  435. Case 2‏‎ (20 revisions)
  436. Cholangiocarcinoma‏‎ (20 revisions)
  437. Fibrous dysplasia‏‎ (20 revisions)
  438. High-grade papillary urothelial carcinoma‏‎ (20 revisions)
  439. Hereditary breast cancer‏‎ (20 revisions)
  440. Chondroblastoma‏‎ (20 revisions)
  441. Porocarcinoma‏‎ (20 revisions)
  442. Usual interstitial pneumonia‏‎ (20 revisions)
  443. Acute cholecystitis‏‎ (20 revisions)
  444. Phosphaturic mesenchymal tumour, mixed connective tissue type‏‎ (20 revisions)
  445. Nasal polyps‏‎ (20 revisions)
  446. Follicular lymphoma‏‎ (20 revisions)
  447. Invasive ductal carcinoma of the breast‏‎ (20 revisions)
  448. Ganglioglioma‏‎ (20 revisions)
  449. Hepatocyte nuclear factor-1beta‏‎ (20 revisions)
  450. Radical cystectomy grossing‏‎ (20 revisions)
  451. Hepatitis B‏‎ (20 revisions)
  452. Giant cells‏‎ (20 revisions)
  453. Juxtaglomerular cell tumour‏‎ (20 revisions)
  454. High-grade prostatic intraepithelial neoplasia‏‎ (20 revisions)
  455. Reactive changes‏‎ (20 revisions)
  456. Avascular necrosis of the femoral head‏‎ (20 revisions)
  457. Lymph node grossing‏‎ (20 revisions)
  458. Intestinal metaplasia of the gallbladder‏‎ (20 revisions)
  459. Small vessel leukocytoclastic vasculitis‏‎ (19 revisions)
  460. Colorectal xanthomatous polyp‏‎ (19 revisions)
  461. Invasive ductal carcinoma of the pancreas‏‎ (19 revisions)
  462. Xanthogranulomatous pyelonephritis‏‎ (19 revisions)
  463. Bizarre parosteal osteochondromatous proliferation‏‎ (19 revisions)
  464. Mucinous tumours of the appendix‏‎ (19 revisions)
  465. Renal cell carcinoma with sarcomatoid differentiation‏‎ (19 revisions)
  466. Ischemic colitis‏‎ (19 revisions)
  467. Schmorl's node‏‎ (19 revisions)
  468. Traditional serrated adenoma‏‎ (19 revisions)
  469. Omentum‏‎ (19 revisions)
  470. Tumour budding‏‎ (19 revisions)
  471. Xanthogranulomatous cholecystitis‏‎ (19 revisions)
  472. Gaucher disease‏‎ (19 revisions)
  473. Miscellaneous ovarian tumours‏‎ (19 revisions)
  474. Paired box gene 8‏‎ (19 revisions)
  475. Epidermal necrosis‏‎ (19 revisions)
  476. Tissue fixation‏‎ (19 revisions)
  477. Keratinising squamous metaplasia of the urinary bladder‏‎ (19 revisions)
  478. Case 47‏‎ (19 revisions)
  479. Carbonic anhydrase 9‏‎ (19 revisions)
  480. Colitis cystica profunda‏‎ (19 revisions)
  481. Pityriasis rubra pilaris‏‎ (19 revisions)
  482. CoPath‏‎ (19 revisions)
  483. MUTYH polyposis syndrome‏‎ (19 revisions)
  484. Foregut primary carcinomas‏‎ (19 revisions)
  485. Hyaline globules‏‎ (18 revisions)
  486. Amebiasis‏‎ (18 revisions)
  487. Drug toxicity‏‎ (18 revisions)
  488. Spermatocytic tumour‏‎ (18 revisions)
  489. Trisomy 13‏‎ (18 revisions)
  490. Clear cell tumours‏‎ (18 revisions)
  491. Diabetes mellitus‏‎ (18 revisions)
  492. Localized cystic disease of the kidney‏‎ (18 revisions)
  493. Testicular scar‏‎ (18 revisions)
  494. Lipoma‏‎ (18 revisions)
  495. Autoimmune metaplastic atrophic gastritis‏‎ (18 revisions)
  496. Testicular adrenal rest tumour‏‎ (18 revisions)
  497. Liposarcoma‏‎ (18 revisions)
  498. Mucinous breast carcinoma‏‎ (18 revisions)
  499. Human papillomavirus-associated head and neck squamous cell carcinoma‏‎ (18 revisions)
  500. Pulmonary carcinoid tumourlet‏‎ (18 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)